BioSpace News Archive

Cynosure announced it entered into partnership with LaserAway, the nation’s leader in aesthetic dermatology, to significantly expand access to Cynosure’s Potenza RF Microneedling system at all their locations nationwide.

Bloomlife, the award winning maternal health company, has received clearance from the US Food and Drug Administration (FDA) for Bloomlife MFM-Pro, their first maternal and fetal monitoring device.

Spineology Inc., the leader in ultra-minimally invasive spine surgery, announced the addition of Amanda Bloom as Executive Vice President, Marketing.

Tarsier Pharma, Ltd. today announced it has received agreement from the U.S. Food and Drug Administration (FDA) under a Special Protocol Assessment (SPA).

The U.S. Food and Drug Administration (FDA) has granted Orphan Drug Designation to Pleco Therapeutics BV’s lead compound, PTX-252 for the treatment of Acute Myeloid Leukaemia (AML).

Hyloris Pharmaceuticals SA (Euronext Brussels: HYL), a specialty biopharma company committed to addressing unmet medical needs through reinventing existing medications, today announces that the U.S. Food and Drug Administration (FDA) has granted Orphan Drug Designation to PTX-252 for the treatment of Acute Myeloid Leukaemia (AML).

The U.S. Food and Drug Administration is providing an at-a-glance summary of news from around the agency.

Celyad Oncology (Euronext: CYAD) (the “Company”), today provides a fourth quarter 2023 business update and an outlook for 2024.

The International Diabetes Federation, in collaboration with Sanofi’s Global Health Unit, is taking significant steps to improve access to diabetes care.

Hemogenyx Pharmaceuticals plc announces the submission of a complete response tothe previously announced Clinical Hold of the Investigational New Drug application to the US Food and Drug Administration for HEMO-CAR-T.